127 related articles for article (PubMed ID: 17237822)
1. FLJ10540-elicited cell transformation is through the activation of PI3-kinase/AKT pathway.
Chen CH; Lu PJ; Chen YC; Fu SL; Wu KJ; Tsou AP; Lee YC; Lin TC; Hsu SL; Lin WJ; Huang CY; Chou CK
Oncogene; 2007 Jun; 26(29):4272-83. PubMed ID: 17237822
[TBL] [Abstract][Full Text] [Related]
2. VEGFA upregulates FLJ10540 and modulates migration and invasion of lung cancer via PI3K/AKT pathway.
Chen CH; Lai JM; Chou TY; Chen CY; Su LJ; Lee YC; Cheng TS; Hong YR; Chou CK; Whang-Peng J; Wu YC; Huang CY
PLoS One; 2009; 4(4):e5052. PubMed ID: 19337377
[TBL] [Abstract][Full Text] [Related]
3. Mcl-1 is an anti-apoptotic factor for human hepatocellular carcinoma.
Fleischer B; Schulze-Bergkamen H; Schuchmann M; Weber A; Biesterfeld S; Müller M; Krammer PH; Galle PR
Int J Oncol; 2006 Jan; 28(1):25-32. PubMed ID: 16327976
[TBL] [Abstract][Full Text] [Related]
4. Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by up-regulating cyclin D1 and down-regulating Bax via a Janus kinase 2-linked pathway.
Chen C; Chang YC; Liu CL; Liu TP; Chang KJ; Guo IC
Endocr Relat Cancer; 2007 Jun; 14(2):513-29. PubMed ID: 17639064
[TBL] [Abstract][Full Text] [Related]
5. Using siRNA to uncover novel oncogenic signaling pathways.
Lai JM; Huang CY; Chen CH
Methods Mol Biol; 2010; 623():231-42. PubMed ID: 20217555
[TBL] [Abstract][Full Text] [Related]
6. NF-kappaB activates transcription of the RNA-binding factor HuR, via PI3K-AKT signaling, to promote gastric tumorigenesis.
Kang MJ; Ryu BK; Lee MG; Han J; Lee JH; Ha TK; Byun DS; Chae KS; Lee BH; Chun HS; Lee KY; Kim HJ; Chi SG
Gastroenterology; 2008 Dec; 135(6):2030-42, 2042.e1-3. PubMed ID: 18824170
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acid-induced HepG2 cell apoptosis.
Tang C; Lu YH; Xie JH; Wang F; Zou JN; Yang JS; Xing YY; Xi T
Anticancer Drugs; 2009 Apr; 20(4):249-58. PubMed ID: 19174695
[TBL] [Abstract][Full Text] [Related]
8. Prevention of TGF-beta-induced apoptosis by interlukin-4 through Akt activation and p70S6K survival signaling pathways.
Lin SJ; Chang C; Ng AK; Wang SH; Li JJ; Hu CP
Apoptosis; 2007 Sep; 12(9):1659-70. PubMed ID: 17624592
[TBL] [Abstract][Full Text] [Related]
9. Phosphatidylinositol-3-kinase/Akt signaling pathway and kidney cancer, and the therapeutic potential of phosphatidylinositol-3-kinase/Akt inhibitors.
Porta C; Figlin RA
J Urol; 2009 Dec; 182(6):2569-77. PubMed ID: 19836781
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic Ras, but not (V600E)B-RAF, protects from cholesterol depletion-induced apoptosis through the PI3K/AKT pathway in colorectal cancer cells.
Calleros L; Sánchez-Hernández I; Baquero P; Toro MJ; Chiloeches A
Carcinogenesis; 2009 Oct; 30(10):1670-7. PubMed ID: 19700418
[TBL] [Abstract][Full Text] [Related]
11. Identification of survival-related genes of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma multiforme.
Ruano Y; Mollejo M; Camacho FI; Rodríguez de Lope A; Fiaño C; Ribalta T; Martínez P; Hernández-Moneo JL; Meléndez B
Cancer; 2008 Apr; 112(7):1575-84. PubMed ID: 18260157
[TBL] [Abstract][Full Text] [Related]
12. Selective down-regulation of glioma-associated oncogene 2 inhibits the proliferation of hepatocellular carcinoma cells.
Kim Y; Yoon JW; Xiao X; Dean NM; Monia BP; Marcusson EG
Cancer Res; 2007 Apr; 67(8):3583-93. PubMed ID: 17440069
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the catalytic subunit of class IA PI3K confer leukemogenic potential to hematopoietic cells.
Horn S; Bergholz U; Jücker M; McCubrey JA; Trümper L; Stocking C; Bäsecke J
Oncogene; 2008 Jul; 27(29):4096-106. PubMed ID: 18317450
[TBL] [Abstract][Full Text] [Related]
14. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D
Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760
[TBL] [Abstract][Full Text] [Related]
15. Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling.
Lee SG; Su ZZ; Emdad L; Sarkar D; Franke TF; Fisher PB
Oncogene; 2008 Feb; 27(8):1114-21. PubMed ID: 17704808
[TBL] [Abstract][Full Text] [Related]
16. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells.
Ye M; Hu D; Tu L; Zhou X; Lu F; Wen B; Wu W; Lin Y; Zhou Z; Qu J
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):497-504. PubMed ID: 18234991
[TBL] [Abstract][Full Text] [Related]
17. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
[TBL] [Abstract][Full Text] [Related]
18. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity.
Lue H; Thiele M; Franz J; Dahl E; Speckgens S; Leng L; Fingerle-Rowson G; Bucala R; Lüscher B; Bernhagen J
Oncogene; 2007 Aug; 26(35):5046-59. PubMed ID: 17310986
[TBL] [Abstract][Full Text] [Related]
19. E-cadherin directly contributes to PI3K/AKT activation by engaging the PI3K-p85 regulatory subunit to adherens junctions of ovarian carcinoma cells.
De Santis G; Miotti S; Mazzi M; Canevari S; Tomassetti A
Oncogene; 2009 Mar; 28(9):1206-17. PubMed ID: 19151754
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells.
Wang J; Yang L; Yang J; Kuropatwinski K; Wang W; Liu XQ; Hauser J; Brattain MG
Cancer Res; 2008 May; 68(9):3152-60. PubMed ID: 18451140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
